News Feature

Nature Biotechnology 27, 309 - 311 (2009)
Corrected online: 8 July 2009 | doi:10.1038/nbt0409-309

There is an Erratum (July 2009) associated with this News Feature.

New relief for gout

Jill U Adams1

  1. Albany, New York

A gout drug has been approved by the FDA, the first in 40 years, with three more in the wings. What accounts for this sudden slew of gout therapies? Jill U. Adams investigates.

* In the version of this article initially published, the incidence of gout was incorrectly stated to be in the hundreds of millions worldwide and 300 million in the US (page 309, paragraph 2). The incidence is known for industrialized countries, not worldwide. In the US, the number is 3 million. The last five lines of the paragraph should have read, "including about 1 in 100 adult men in industrialized countries (an estimated 3 million in the US according to the Centers for Disease Control)." The errors have been corrected in the HTML and PDF versions of the article.


These links to content published by NPG are automatically generated.


Acute inflammatory arthritis Interleukin-1 blockade: a magic wand for gout?

Nature Reviews Rheumatology News and Views (01 Nov 2009)

Epidemiology Gout???bad for the heart as well as the joint

Nature Reviews Rheumatology News and Views (01 Jul 2010)